Mylan (MYL +3.5%) says one of its subsidiaries has received approval for three antiretroviral...

|About: Mylan Inc (MYL)|By:, SA News Editor

Mylan (MYL +3.5%) says one of its subsidiaries has received approval for three antiretroviral therapies used to treat HIV/AIDS under the World Health Organization's Prequalification of Medicines Program.